Skip to main content

Jaspers Reacts to $40 Million Juul Settlement with State of North Carolina

July 1, 2021
Ilona Jaspers, PhD, and Adam Goldstein, MD, MPH, share their responses to the terms of e-cigarette manufacturer Juul Labs’ settlement in a lawsuit from North Carolina’s attorney general. Read their opinions here on what this means for the state and the future of youth vaping.

Tarran to Give The Physiological Society’s Hodgkin-Huxley-Katz Prize Lecture

June 30, 2021
The Society’s Hodgkin-Huxley-Katz Prize Lecture is a prestigious biennial lecture, awarded to distinguished physiologists working outside the United Kingdom or Republic of Ireland. Read the fully story here.

Kreda et al Demonstrate Promising New Approach for Treating Cystic Fibrosis

June 30, 2021
Scientists led by UNC School of Medicine researchers Silvia Kreda, PhD, and Rudolph Juliano, PhD, created an improved oligonucleotide therapy strategy with the potential for treating other pulmonary diseases, such as COPD and asthma. Read the full story here.

Kesimer Study on COPD Profiled in WRAL TechWire Story

June 30, 2021
A study by the Kesimer lab published in Lancet Respiratory Medicine has been profiled in a WRAL TechWire article, “Elevated level of lung protein could be early predictor for COPD, UNC says.” Mehmet Kesimer, PhD, is the study’s senior author, and the lead author is Giorgia Radicioni, PhD. The WRAL article...

Henderson Consulted for News Stories on Decreasing Number of COVID-19 Patients

June 30, 2021
Ashley Henderson, MD, has been consulted for ABC11 and FOX29 news stories that highlight the milestone of UNC Health having zero COVID-19 patients for a 36-hour period, the longest span in over a year. Read the ABC11 story, “UNC Health reaches milestone of zero COVID patients for 36-hour span,” here....

Radicioni, Kesimer Lab: Is Elevated Level of Lung Protein an Early Predictor for COPD?

June 4, 2021
The UNC School of Medicine lab of Mehmet Kesimer, PhD, discovered MUC5AC is more reliably associated with the manifestation of COPD than another well-known mucus protein, revealing a possible biomarker of disease initiation, prognosis, and therapeutic effectiveness. The results of their study, in a paper first-authored by Giorgia Radicioni, PhD,...

Peden Consulted for Multiple News Stories Concerning Allergic Reactions to Some COVID-19 Vaccines

April 29, 2021
David Peden, MD, has been consulted for a number of news stories focusing on UNC research to understand allergic reactions to some COVID-19 vaccines. The stories and accompanying videos can be found at the links below. Fox 8: What’s causing allergic reactions to some COVID-19 vaccines? UNC working on an...

Bennett et al: Fit Matters Most When Double Masking to Protect Yourself from COVID-19

April 27, 2021
A study led by Emily Sickbert-Bennett, PhD, associate professor of infectious diseases at the UNC School of Medicine and director of UNC Medical Center Infection Prevention, and William D. Bennett, PhD, professor of medicine in the UNC Center for Environmental Medicine, Asthma, and Lung Biology, shows that wearing two masks...

Ehre’s SARS-CoV-2 Image Featured in The Well’s Article About a COVID-19 Antiviral

February 11, 2021
A SARS-CoV-2 image produced by Camille Ehre, PhD, and published in The New England Journal of Medicine has been featured in an article in The Well. The article, “Antiviral proves effective at preventing and treating COVID-19,” can be read here. Referred to in the article is a paper recently published in...

Knowles Consulted for Canadian Insider Article About COVID-19 Therapeutics

February 4, 2021
Michael R. Knowles, MD, has been consulted for an article in the Canadian Insider entitled “EmitBio Announces Positive Clinical Results Supporting a Novel Therapeutic for COVID-19.” The article can be read here.